BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3654901)

  • 21. Second cancers following in situ carcinoma of the breast.
    Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
    Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathobiology of breast cancer--treatment implications.
    Vorherr H
    Eur J Obstet Gynecol Reprod Biol; 1984 May; 17(2-3):219-35. PubMed ID: 6329835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second primary cancer after treatment of invasive carcinoma of the uterine cervix, compared with those arising after treatment for in situ carcinomas. An effect of irradiation? A cancer registry study.
    Pettersson F; Ryberg M; Malker B
    Acta Obstet Gynecol Scand; 1990; 69(2):161-74. PubMed ID: 2386020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A contribution to the natural history of breast cancer. V. Bilateral primary breast cancer: incidence, risks and diagnosis of simultaneous primary cancer in the opposite breast.
    Tulusan AH; Ronay G; Egger H; Willgeroth F
    Arch Gynecol; 1985; 237(2):85-91. PubMed ID: 4083918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up.
    Rosen PP; Groshen S; Kinne DW; Hellman S
    Surgery; 1989 Nov; 106(5):904-10. PubMed ID: 2814824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second primary cancers following female breast cancer in Osaka, Japan--a population-based cohort study.
    Murakami R; Hiyama T; Hanai A; Fujimoto I
    Jpn J Clin Oncol; 1987 Dec; 17(4):293-302. PubMed ID: 3694826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second primary cancers of the breast: incidence and risk factors.
    Hislop TG; Elwood JM; Coldman AJ; Spinelli JJ; Worth AJ; Ellison LG
    Br J Cancer; 1984 Jan; 49(1):79-85. PubMed ID: 6691900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pathologic Finding of Combined Lobular Carcinoma
    Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
    Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation dose and second breast cancer.
    Basco VE; Coldman AJ; Elwood JM; Young ME
    Br J Cancer; 1985 Sep; 52(3):319-25. PubMed ID: 4041361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of lobular carcinoma in bilateral breast cancer.
    Lewis TR; Casey J; Buerk CA; Cammack KV
    Am J Surg; 1982 Dec; 144(6):635-8. PubMed ID: 6293326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of contralateral breast cancer. Associations with histologic, clinical, and therapeutic factors.
    Horn PL; Thompson WD
    Cancer; 1988 Jul; 62(2):412-24. PubMed ID: 3383140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contralateral breast cancer: incidence according to ductal or lobular phenotype of the primary.
    Langlands F; White J; Kearins O; Cheung S; Burns R; Horgan K; Sharma N; Dodwell D
    Clin Radiol; 2016 Feb; 71(2):159-63. PubMed ID: 26703116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographic differences in invasive and in situ breast cancer incidence according to precise geographic coordinates, Connecticut, 1991-95.
    Gregorio DI; Kulldorff M; Barry L; Samociuk H
    Int J Cancer; 2002 Jul; 100(2):194-8. PubMed ID: 12115569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Summary: multiple primary cancers in Connecticut, 1935-82.
    Curtis RE; Boice JD; Kleinerman RA; Flannery JT; Fraumeni JF
    Natl Cancer Inst Monogr; 1985 Dec; 68():219-42. PubMed ID: 4088299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second cancer following cancer of the female genital system in Connecticut, 1935-82.
    Curtis RE; Hoover RN; Kleinerman RA; Harvey EB
    Natl Cancer Inst Monogr; 1985 Dec; 68():113-37. PubMed ID: 4088293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer.
    Bernstein JL; Thompson WD; Risch N; Holford TR
    Am J Epidemiol; 1992 Oct; 136(8):925-36. PubMed ID: 1456269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lobular carcinoma in situ. A long-term follow-up in 52 cases.
    Andersen JA
    Acta Pathol Microbiol Scand A; 1974 Jul; 82(4):519-33. PubMed ID: 4853025
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer.
    Smith BL; Bertagnolli M; Klein BB; Batter S; Chang M; Douville LM; Eberlein TJ
    Ann Surg; 1992 Jul; 216(1):17-21. PubMed ID: 1321595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant melanoma associated with breast cancer.
    Schoenberg BS; Christine BW
    South Med J; 1980 Nov; 73(11):1493-7. PubMed ID: 7444518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.